Drug Pipeline

Fexofenadine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
4
Phase 3
6
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT07118215
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine…		 date change Primary completion pushed: 2026-04-05 -> 2026-06-25
2026-06-12 NCT07118215
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine…		 date change Completion pushed: 2026-04-05 -> 2026-06-25
Active Studies by Phase
Phase 3
3
Phase 2/3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07381803 The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute… Zhejiang University Recruiting
NCT05263206 Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants… Pruritus Recruiting
NCT04688788 Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis Relapsing Remitting Multiple Sclerosis Active, Not Recruiting
Phase 2/3
NCT06785298 Fexofenadine as Adjuvant Therapy in Parkinson Disease Parkinson Disease Recruiting
Phase 2
NCT07526558 Mast Cell Treatment in Post-tick Bite Illness (PTBI) Post-tick Bite Illness Not Yet Recruiting
Phase 1
NCT07118215 A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine… Healthy Volunteers Recruiting
Sponsors Running Fexofenadine Trials
Rigshospitalet, Denmark (1) Sanofi (1) Tanta University (1) Karuna Therapeutics, Inc., a Bristol Myers Squibb company (1) Second Affiliated Hospital, School of Medicine, Zhejiang University (1) University of North Carolina, Chapel Hill (1)
Disease Areas
Multiple Sclerosis (1) Parkinson's Disease (1)
Get alerts when Fexofenadine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free